| Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
|---|
| 05/16/2006 | CA2237752C Novel substituted aryl compounds useful as modulators of acetylcholine receptors |
| 05/11/2006 | WO2006050435A1 Heterocyclical chromophore architectures |
| 05/11/2006 | WO2006049986A1 Polymorphic forms of tadalafil |
| 05/11/2006 | WO2006048750A2 Novel compounds of substituted and unsubstituted adamantyl amides |
| 05/11/2006 | US20060100245 Substituted biphenyl-4-carboxylic acid arylamide analogues |
| 05/11/2006 | CA2585735A1 Novel compounds of substituted and unsubstituted adamantyl amides |
| 05/11/2006 | CA2585645A1 Ceramides and apoptosis-signaling ligand |
| 05/11/2006 | CA2584869A1 Heterocyclical chromophore architectures |
| 05/11/2006 | CA2584796A1 Heterocyclical anti-aromatic chromophore architectures |
| 05/11/2006 | CA2584792A1 Heterocyclical chromophore architectures |
| 05/10/2006 | EP1655303A2 Hydroxylamine esters as polimerization initiators |
| 05/10/2006 | EP1654324A1 Sulphonamide anions as catalysts for nco oligomerisation |
| 05/10/2006 | EP1653962A2 Pyrazine modulators of cannabinoid receptors |
| 05/10/2006 | EP1427731B1 Process for the preparation of highly pure triethylene diamine |
| 05/10/2006 | EP1282630B1 Process for Reducing the Molecular Weight of Polypropylene Using Hydroxylamine Esters |
| 05/10/2006 | CN1769274A Pyrazinone protease inhibitors |
| 05/10/2006 | CN1255401C Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists |
| 05/09/2006 | US7041826 Process for preparing 1-methyl-3-phenylpiperazine using a novel intermediate |
| 05/09/2006 | US7041672 Substituted aryl 1, 4-pyrazine derivatives |
| 05/09/2006 | US7041670 Florfenicol-type antibiotics |
| 05/09/2006 | CA2125105C Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic and medicament containing them |
| 05/04/2006 | WO2006023573A3 Aliphatic amide & ester pyrazinoylguanidine sodium channel blockers |
| 05/03/2006 | EP1651622A1 Process for the preparation of 2- (quinoxalin-5-ylsulfonylamino) -benzamide compounds |
| 05/03/2006 | EP1651621A1 2- (quinoxalin-5-ylsulfonylamino) -benzamide compounds as cck2 modulators |
| 05/03/2006 | EP1651620A2 Piperazine derivatives and their use as therapeutic agents |
| 05/03/2006 | EP1651235A2 Sigma-1 receptor ligand with acetylcholinesterase inhibition properties |
| 05/03/2006 | EP1562902B1 2-pyridone derivatives as inhibitors of neutrophile elastase |
| 05/03/2006 | EP1208091B1 Benzophenones as inhibitors of reverse transcriptase |
| 05/03/2006 | EP1188755B1 Acylhydrazine derivatives, process for preparing the same and use thereof |
| 05/02/2006 | USRE39088 Amide compounds and use of the same |
| 05/02/2006 | US7037913 Piperazinyl derivatives of naphthalenes, (iso)quinolines and naphthyridines; used particularly the treatment of HIV and AIDS. |
| 05/02/2006 | CA2326804C Compounds with activity on muscarinic receptors |
| 04/27/2006 | WO2006043064A1 Piperidines and related compounds for treatment of alzheimer's disease |
| 04/27/2006 | WO2006019957A3 Heterocyclyls as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
| 04/27/2006 | US20060089371 Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist |
| 04/27/2006 | US20060089368 Phenyl-piperazine derivatives as serotonin reuptake inhibitors |
| 04/27/2006 | CA2584504A1 Piperidines and related compounds for treatment of alzheimer's disease |
| 04/26/2006 | EP1648459A1 Sir2 regulation |
| 04/26/2006 | CN1762965A A method for inhibiting polymerization of (meth) acrylic acid and its esters using an inhibitor and a process for making a compound useful as such an inhibitor |
| 04/26/2006 | CN1253442C Novel thiazine or pyrazine derivatives |
| 04/25/2006 | US7034035 Having a high residual activity, greater activity at lower application rates, curative activity, and a broader spectrum of efficacy; heterocyclic aromatic amides having a hydroxy group adjacent to the amide functionality |
| 04/25/2006 | US7034026 serine/threonine kinase inhibitors; 2,3-diphenylquinoxalines in which at least one of the phenyls is substituted with an amine group, particularly 2-[4-(2-aminoprop-2-yl)phenyl]-3-phenylquinoxaline; treating cancer |
| 04/25/2006 | US7034025 Administering to a mammal an effective dose of a cysteine derivatives containing heteroaromatic group for the treatment of arterial tension, embryogenesis, oncogenesis, diabetes, cell proliferation, and other diseases |
| 04/25/2006 | CA2194885C Substituted benzamidines, their preparation and their use as pharmaceutical compounds |
| 04/20/2006 | WO2006041119A1 Hydrazide derivatives |
| 04/20/2006 | WO2006040568A1 Quinoxalines as b raf inhibitors |
| 04/20/2006 | WO2006021002A3 Compounds useful for inhibiting chk1 |
| 04/20/2006 | US20060084809 Compounds as PDE IV and TNF-inhibitors |
| 04/20/2006 | US20060084662 E.g., 4-[2-(4-Methylphenoxy)- or 4-[2-(4-Methylphenylsulfanyl)-phenyl]-3,6-dihydro-2H-pyridine or the hydrochloride or oxalate; treating depression, anxiety disorder, and obsessive compulsive disorder. |
| 04/20/2006 | US20060084658 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound |
| 04/20/2006 | US20060084651 Chemical compounds |
| 04/20/2006 | US20060084641 IL-8 receptor antagonists |
| 04/20/2006 | DE19941915B4 Aroma von gebratenen Kartoffeln und entsprechend aromatisierte Nahrungsmittel Aroma of fried potatoes and according flavored foods |
| 04/20/2006 | CA2583096A1 Quinoxalines as b raf inhibitors |
| 04/19/2006 | EP1420784B1 Compounds effecting glucokinase |
| 04/19/2006 | EP1253924B1 Nitrate salts of antimicrobial agents |
| 04/19/2006 | EP1212330B1 Androgen receptor modulator compounds and methods |
| 04/19/2006 | EP1177176B1 Tri-aryl acid derivatives as ppar receptor ligands |
| 04/19/2006 | EP1064274B1 Benzenesulfonamide derivatives and their use as medicaments |
| 04/19/2006 | CN1761642A Process for the preparation of chiral beta amino acid derivatives by asymmetric hydrogenation |
| 04/18/2006 | US7030242 Selective inhibition of aggrecanase in osteoarthritis treatment |
| 04/18/2006 | US7030196 Process for reducing the molecular weight of polypropylene |
| 04/18/2006 | US7030122 1,4-disubstituted piperazine ligands for neurotransmitter receptors |
| 04/18/2006 | US7030117 Sodium channel blockers |
| 04/18/2006 | US7030111 drugs such as 4-chloro-benzoic acid p-tolyl ester, used to control or suppress the onset of mitosis until DNA replication and repair are complete; prophylaxis of proliferative disorders |
| 04/18/2006 | CA2360943C N2-phenylamidine derivatives |
| 04/13/2006 | WO2006023849A3 Catalysis of diketopiperazine synthesis |
| 04/13/2006 | US20060079530 Farnesyl transferase inhibitors |
| 04/13/2006 | US20060079528 Carbamic acid compounds comprising a bicyclic heteroaryl group as hdac inhibitors |
| 04/12/2006 | EP1645552A1 Double-spiro organic compounds and electroluminescent devices |
| 04/12/2006 | EP1644365A2 Pyrazine and pyridine derivatives as rho kinase inhibitors |
| 04/12/2006 | EP1644322A1 Aspartyl protease inhibitors |
| 04/12/2006 | EP1644321A2 New benzamides as ppaty modulators |
| 04/12/2006 | EP1087981B1 Prenyl transferase inhibitors |
| 04/12/2006 | CN1250559C Process for preparing amine platinum complexes |
| 04/12/2006 | CN1250553C Antidepressant azaheterocyclylmethyl derivatives of 2, 3-dihydro-1,4-dioxino [2,3-f] quinoxaline |
| 04/12/2006 | CN1250539C Intermediate for preparing 1-[halogenarylradical] heterocyclic pesticide compound |
| 04/11/2006 | US7026485 inhibitors of HIV protease; N-heterocyclic moiety containing hydroxyethylamine compounds where the heterocyclic moiety may be octahydroisoquinoline |
| 04/11/2006 | US7026478 Iron catalyzed cross coupling reactions of aromatic compounds |
| 04/11/2006 | US7026325 pyrazinoylguanidine compounds, e.g., 4-{4-[N-(3,5-diamino-6-chloropyrazine-2-carbonyl)guanidino]butyl}-N-(2-aminoethyl)benzamide hydrochloride; are absorbed less rapidly from mucosal surfaces, especially airway surfaces; rehydration of mucosal surfaces; reducing blood pressure |
| 04/11/2006 | US7026324 Amide containing a pyridinone or pyrazinone compound as serine protease enzyme inhibitors |
| 04/11/2006 | US7026322 Anticancer agents; fungicides |
| 04/11/2006 | US7026318 Compounds exhibiting X-type sPLA2 inhibiting effect |
| 04/11/2006 | US7026019 Anisotropic films based on 1,8-naphthoylene-1′,2′-benzimidazole sulfonates and lyotropic liquid crystal systems and methods for making |
| 04/11/2006 | CA2217030C Protease inhibiting succinic acid derivatives |
| 04/06/2006 | WO2005123737A9 Charge-transport materials, methods of fabrication thereof, and methods of use thereof |
| 04/06/2006 | US20060074243 Hydroxamic acid and amide compounds and their use as protease inhibitors |
| 04/06/2006 | US20060074111 Chemical compounds |
| 04/06/2006 | US20060074072 2-[3-(4-chlorophenyl)ureido] N-[4-(2-oxo-2H-pyridin-1-yl)phenyl]-4-methanesulfonylbutyramide; prophylaxis and/or therapy of thromboembolic diseases and for the treatment of tumors |
| 04/05/2006 | EP1641779A1 2-substitued 5, 6-diaryl-pyrazine derivatives as cb1 modulator. |
| 04/05/2006 | EP1641777A1 Indole derivatives with apoptosis-inducing effect |
| 04/05/2006 | EP1641748A2 N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer s disease |
| 04/05/2006 | EP1641535A2 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 04/05/2006 | EP1392308B1 Ophthalmically acceptable compositions comprising an alpha-2-adrenergic agonist and a fatty acid |
| 04/05/2006 | CN1249056C Inhibitors of dipeptidyl peptidase IV |
| 04/04/2006 | US7022845 Monomethylation of nitrogeneous heterocycles |
| 04/04/2006 | US7022707 such as S-4-[(2-propylamino)carbonyl]oxybenzyl piperazine-1-thiocarboxylate for treatment of obesity and/or diabetes |
| 04/04/2006 | US7022704 5,6,7, 8-tetrahydro-imidazo-(1,2a)-pyrazine derivative; useful for treating restenosis and tumor |
| 03/30/2006 | WO2006034277A1 Bicyclic compounds which inhibit beta-secretase activity and methods of use thereof |
| 03/30/2006 | WO2005123089A3 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease |